Posted in Diseases

Download 50 Studies Every Internist Should Know by Kristopher J. Swiger, Joshua R. Thomas, Michael E. Hochman, PDF

By Kristopher J. Swiger, Joshua R. Thomas, Michael E. Hochman, Steven D. Hochman

50 experiences each Internist should still Know offers key reports that experience formed the perform of inner medication. chosen utilizing a rigorous method, the reviews conceal themes together with: preventative drugs, endocrinology, hematology and oncology, musculoskeletal ailments, nephrology, gastroenterology, infectious ailments, cardiology, pulmonology, geriatrics and palliative care, and psychological future health. for every learn, a concise precis is gifted with an emphasis at the effects and boundaries of the examine, and its implications for perform. An illustrative scientific case concludes every one evaluation, through short details on different appropriate reviews. This ebook is a must-read for health and wellbeing care pros and someone who desires to examine extra in regards to the facts at the back of scientific perform.

Show description

Read or Download 50 Studies Every Internist Should Know PDF

Best diseases books

Glucokinase And Glycemic Disease: From Basics to Novel Therapeutics (Frontiers in Diabetes)

The glucose-phosphorylating enzyme glucokinase (also referred to as hexokinase IV) performs a preeminent position as a glucose sensor and regulatory metabolic enzyme. the results of this vital place of glucokinase for the certainty and therapy of diabetes mellitus are a ways attaining. This booklet addresses the molecular and human genetic, in addition to the physiological-chemical and pharmacological features of the position glucokinase performs in glucose homeostasis and illnesses of glucose metabolism, and the way the enzyme serves because the drug aim for the therapy of diabetes mellitus.

Abeta Peptide and Alzheimer's Disease: Celebrating a Century of Research

Contemporary advances in genetics and mind biochemistry element to the Abeta peptide because the significant perpetrator in inflicting neurodegeneration in Alzheimer’s illness (AD). This publication summarizes present wisdom of the Abeta peptide and its position in advert. Written through experts during this fast paced zone, the publication covers basic biochemical reviews in this peptide, the genetic influence on Abeta expression and processing, and diverse advert healing ideas that concentrate on Abeta.

Clinician's Guide to Chronic Obstructive Pulmonary Disease (Hodder Arnold Publication)

Clinicians' consultant to COPD considers epidemiology, analysis and administration, focusing on how sufferers particularly current to the clinician. features of ailment prevention, together with way of life switch, really smoking cessation, might be mentioned intimately. Acute exacerbation of COPD, at the moment an incredible reason for mortality and morbidity in those sufferers, can be tested.

Additional resources for 50 Studies Every Internist Should Know

Example text

JAMA. 2010;304(15):1684–1692. 9. Salpeter SR et al. Brief report: Coronary heart disease events associated with hormone therapy in younger and older women: a meta-analysis. J Gen Intern Med. 2006;21(4):363. Schierbeck LL et al. Effect of hormone replacement therapy on cardiovas cular events in recently postmenopausal women: randomised trial. BMJ. 2012;345:e6409. 11. Moyer VA, US Preventive Services Task Force. S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013;158(1):47.

The ERSPC trial is ongoing, and future analyses will provide longer term follow-up data. In the meantime, guidelines from the US Preventive Services Task Force recommend against routine screening. CLINICAL CASE: SCREENING FOR PROSTATE CANCER Case History: A 50-year-old African American man whose father died from prostate cancer at the age of 64 presents to your clinic for a routine evaluation. Based on the results of the ERSPC trial, do you recommend prostate cancer screening for this patient? Suggested Answer: The ERSPC trial found that screening for prostate cancer with PSA testing every 4 years leads to a small reduction in prostate cancer deaths along with a substantial increase in the (potentially unnecessary) diagnosis and treatment of prostate cancer.

There was no effect of screening on all-cause mortality, though the study was not powered for this analysis. The ERSPC trial is ongoing, and future analyses will provide longer term follow-up data. In the meantime, guidelines from the US Preventive Services Task Force recommend against routine screening. CLINICAL CASE: SCREENING FOR PROSTATE CANCER Case History: A 50-year-old African American man whose father died from prostate cancer at the age of 64 presents to your clinic for a routine evaluation.

Download PDF sample

Rated 4.29 of 5 – based on 3 votes